tirzepatide patent expiry date Semaglutide in India to trigger a wave of cheaper generics Novo Nordisk patent expiry opens

Available evidence from diabetes and obesity trials demonstrates substantial weight regain after discontinuation of GLP-1 RAs, reaching pre-treatment levels in some cohorts within 12-18 months of cessation, with accompanying deterioration in cardiometabolic parameters [72]

Resveratrol Studies suggest that resveratrol, an antioxidant, may help with weight loss in people with obesity by reducing fat mass and improving body composition

Semaglutide also helps weight loss through other actions that do not depend on making sugar low: It reduces appetite and increases fullness by acting on satiety centres in the brain It slows stomach emptying, so you feel full sooner and longer So, in a non-diabetic person, the body still has normal safety systems, and semaglutide mainly helps by reducing calorie intake, not by forcing sugar down

Studies show that injecting MT2 into specific hypothalamic nuclei (like the ventromedial hypothalamus) increases glucose uptake in peripheral tissues, helping researchers map distinct hypothalamic roles in glucose regulation

"With no new FDA-approved medications for AUD since 2006, identifying new therapeutic options is especially critical